Historical position

Fidelity Investments’s Chemours Co (CC) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

FMR LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2016Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares30.51MHighest verified quarter-end share count
Quarters reported26Verified quarters with shares above zero
What happened?

FMR LLC first reported Chemours Co in Q4 2016. The reported position was increased and reduced across later filings. Verified positive position history runs through Q2 2025. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2025
Sold 67.7% of the position−10.77M shares · 5.14M shares remained
Filing context

Quarter-end price $11.45

Q2 2024
Sold 10.4% of the position−2.03M shares · 17.52M shares remained
Filing context

Quarter-end price $22.57

Q3 2023
Sold 7.8% of the position−1.48M shares · 17.44M shares remained
Filing context

Quarter-end price $28.05

Q2 2023
Sold 38.0% of the position−11.59M shares · 18.92M shares remained
Filing context

Quarter-end price $36.89

Q1 2023
Bought 157.9% more+18.68M shares · 30.51M shares reported after the change
Filing context

Quarter-end price $29.94

Q4 2022
Bought 20.5% more+2.01M shares · 11.83M shares reported after the change
Filing context

Quarter-end price $30.62

Portfolio importance

How important was Chemours Co in FMR LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q2 2025
Last reported rank#1332Rank unavailable
Peak portfolio weight0.1%Q1 2018
Best historical rank#156Q1 2018
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$14.192026-09-24

Market context only; not an investor transaction price.

Latest filing quarter-end price$11.45Q2 2025

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to Fidelity’s top reported positions and material events rather than every security in each Form 13F. The consolidated FMR LLC filing includes multiple Fidelity investment managers. Source filings may contain additional securities, and 13F filings do not reveal exact trade dates or execution prices.